After graduating in medicine from the University of Adelaide John McNeil undertook specialist training to become qualified as a consultant in internal medicine and clinical pharmacology. He completed a PhD in Clinical Pharmacology at Melbourne University. He headed the Monash University Department (&subsequently School) of Public Health & Preventive Medicine from 1986-Jan 2019, developing a core of methodological skills in epidemiology, clinical medicine, bio statistics & data-management. His principal research interest is in large community-based intervention trials and was the initiator of the ASPREE trial. His other interest is clinical registry science
Aspirin for the Primary Prevention of Cardiovascular Disease – Represented in NEJM by the ASPREE and ASCEND trials (and in Lancet by the ARRIVE trial).
Event: ESC Congress 2019
Topic: European Society of Cardiology
Session: Highlights from the New England Journal of Medicine: editors’ choice
